IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.085
NA - Nord America 1.180
EU - Europa 636
SA - Sud America 269
AF - Africa 43
OC - Oceania 14
Totale 7.227
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.795
US - Stati Uniti d'America 1.105
CN - Cina 626
HK - Hong Kong 369
BR - Brasile 208
IT - Italia 156
GB - Regno Unito 154
VN - Vietnam 146
DE - Germania 82
NL - Olanda 65
CA - Canada 42
IN - India 40
FI - Finlandia 36
MX - Messico 28
JP - Giappone 20
AR - Argentina 19
AT - Austria 19
ID - Indonesia 19
ES - Italia 18
TR - Turchia 18
ZA - Sudafrica 17
EC - Ecuador 16
PL - Polonia 16
UA - Ucraina 16
FR - Francia 15
AU - Australia 12
BD - Bangladesh 12
LT - Lituania 11
EG - Egitto 10
CO - Colombia 9
RU - Federazione Russa 9
PE - Perù 8
IR - Iran 7
DK - Danimarca 6
CZ - Repubblica Ceca 5
SE - Svezia 5
BG - Bulgaria 4
CL - Cile 4
IL - Israele 4
UZ - Uzbekistan 4
EE - Estonia 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MY - Malesia 3
RO - Romania 3
TH - Thailandia 3
TL - Timor Orientale 3
TN - Tunisia 3
BO - Bolivia 2
GT - Guatemala 2
IE - Irlanda 2
KZ - Kazakistan 2
LV - Lettonia 2
NC - Nuova Caledonia 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BJ - Benin 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
YT - Mayotte 1
Totale 7.227
Salva come PNG Salva come JPEG
Città #
Singapore 405
Hong Kong 362
Dallas 262
Hefei 257
Ashburn 219
Boardman 135
Beijing 123
London 120
Shanghai 81
Council Bluffs 73
Ho Chi Minh City 56
Amsterdam 54
Munich 50
Rome 41
Los Angeles 37
Hanoi 30
Santa Clara 25
Turku 23
São Paulo 19
Toronto 18
Ankara 16
San Francisco 16
Bari 15
Pune 15
Tokyo 15
Washington 15
Brooklyn 14
Mexico City 14
New York 14
Warsaw 14
Atlanta 12
Haiphong 12
Helsinki 12
Chennai 11
Hangzhou 10
Boston 9
Jinan 9
Johannesburg 9
Seattle 9
Chicago 8
Jaguariúna 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Leicester 7
Montreal 7
Charlotte 6
Guayaquil 6
Las Vegas 6
Melbourne 6
Milan 6
Naples 6
Manaus 5
Paris 5
Pisa 5
Rio de Janeiro 5
Vienna 5
Brasília 4
Brno 4
Chaozhou 4
Cotia 4
Da Nang 4
Hải Dương 4
Kongens Lyngby 4
Noicattaro 4
Porto Alegre 4
Secaucus 4
Shijiazhuang 4
State College 4
Stockholm 4
Sydney 4
Thái Bình 4
Xi'an 4
Bauru 3
Biên Hòa 3
Buenos Aires 3
Can Tho 3
Cape Town 3
Chengdu 3
Denver 3
Dili 3
Frankfurt am Main 3
Guarulhos 3
Lima 3
Nairobi 3
New Delhi 3
Poplar 3
Quito 3
Redmond 3
Sofia 3
São Luís 3
Tel Aviv 3
Tunis 3
Alexandria 2
Americana 2
Anantapur 2
Barcelona 2
Barranquilla 2
Totale 2.894
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 204
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 199
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 197
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 192
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 186
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 180
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 175
Leptin in immuno-rheumatological diseases 172
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 169
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 167
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 153
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 152
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 129
Adult-onset Still's disease with elderly onset: results from a multicentre study 126
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 123
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 121
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 108
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 101
A longitudinal study on caring behaviors of Italian nursing students 97
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 97
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 96
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 95
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 90
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 90
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 90
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 89
Cannabinoids in Autoimmune and Rheumatic Diseases 88
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 88
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 88
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 86
Leptin in autoimmune mechanisms of systemic rheumatic diseases 85
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 84
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 69
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 67
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 67
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 65
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 59
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 56
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 56
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 54
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 51
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 49
Polypharmacy is a determinant of hospitalization in Parkinson's disease 49
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 45
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 44
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 43
Development and implementation of the AIDA International Registry for patients with Behçet's disease 41
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 41
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 38
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 38
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 37
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 37
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 37
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 36
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 36
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 36
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 36
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 35
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 35
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 35
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 35
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 35
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 35
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 34
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 33
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 33
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 33
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 32
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 32
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 32
Matters of the heart: The case of TNF-alpha targeting drugs 32
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 32
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 32
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 31
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 31
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 31
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 30
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 30
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 30
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 30
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 30
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 29
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 29
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 28
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 28
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 28
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 28
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 28
Endothelial-to-mesenchymal transition in systemic sclerosis 28
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 28
Utility of ultrasound in the diagnosis of chronic worsened gout 27
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 27
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 27
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 27
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 27
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 26
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 26
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 26
Totale 6.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20261.838 490 229 479 528 112 0 0 0 0 0 0 0
Totale 7.351